The broader enforcement focus: Botox-type products, ophthalmics, clinical trials, recalls The RAPS article also highlights other key enforcement priorities for CDER in 2025: The agency issued 18 warning letters to firms marketing fraudulent or unapproved Botox-type products, warning that such products pose serious safety risks, including potential counterfeiting, incorrect/inactive ingredients, or falsification
Key areas of active scientific investigation utilizing GHK-Cu 1g include: Extracellular Matrix (ECM) Synthesis Kinetics: Modeling the intracellular signaling loops that govern the transcription of structural proteins
All sales are for laboratory research use only, not for human or veterinary consumption
Zhu, Z.-F., Wang, Q.-G., Han, B.-J